ClinicalTrials.Veeva

Menu
I

Imelda Vzw | Study Cardiology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Gemcitabine
Durvalumab
9-ING-41
Felzartamab
Filgotinib
-Paclitaxel
SBP-101
Tislelizumab
RVX000222
Bevacizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 11 total trials

9-ING-41 in Patients with Advanced Cancers

GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and e...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: 9-ING-41

This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzum...

Active, not recruiting
Gastroesophageal Adenocarcinoma
Gastric Neoplasms
Drug: Tislelizumab
Drug: Capecitabine

The purpose of this study is to evaluate the efficacy and safety of Zanidatamab plus CisGem (Cisplatin and Gemcitabine) with or without the addition...

Enrolling
Biliary Tract Cancer
Drug: Cisplatin
Drug: Gemcitabine

The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or with...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Trial sponsors

Jazz Pharmaceuticals logo
AVEO Pharmaceuticals logo
A
A
B
P
Pierre Fabre logo
R
Takeda logo
H

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems